Influence of systemic fluoroquinolone administration on the presence of Pasteurella multocida in the upper respiratory tract of clinically healthy calves [PDF]
, 2008 Boudewijn Catry +8 more
openalex +1 more source
The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens [PDF]
, 1998 F. W. Goldstein +6 more
openalex +1 more source
ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food‐producing animals [PDF]
, 2017 Reilly, Jacqui
core +1 more source
Next generation macrolides for community-acquired pneumonia: will solithromycin rise to the occasion? [PDF]
, 2017 Jose, RJ
core +1 more source
Clinical experience with fluoroquinolones for treatment of severe Chlamydia psittaci pneumonia with invasive mechanical ventilation in ICU: a retrospective study. [PDF]
Front Med (Lausanne)Feng B +5 more
europepmc +1 more source
230Antimicrobial Stewardship Strategy to Decrease Respiratory Fluoroquinolone Utilization in a Large, Urban, Healthcare System [PDF]
, 2014 Theresa Jaso +4 more
openalex +1 more source
Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]
Saudi Pharm JAlshammari TM.
europepmc +1 more source